Concurrence of villous adenoma and non-muscle invasive bladder cancer arising in the bladder: a case report and review of the literature

被引:15
作者
Kato, Yoichiro [1 ]
Konari, Susumu [2 ]
Obara, Wataru [1 ]
Sugai, Tamotsu [3 ]
Fujioka, Tomoaki [1 ]
机构
[1] Iwate Med Univ, Dept Urol, Morioka, Iwate 0208505, Japan
[2] Ninohe Prefectural Hosp, Dept Urol, Ninohe, Iwate, Japan
[3] Iwate Med Univ, Dept Diagnost Pathol, Morioka, Iwate 0208505, Japan
来源
BMC UROLOGY | 2013年 / 13卷
基金
日本学术振兴会;
关键词
Urinary bladder neoplasms; Villous adenoma; Urothelial carcinoma; PAPILLARY ADENOCARCINOMA; URINARY-BLADDER; URETHRA; TRACT;
D O I
10.1186/1471-2490-13-36
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Villous adenoma arising in the urinary tract is rare tumor. Most cases have been identified as benign neoplasm in the colon. Villous adenoma of the gastrointestinal tract is thought arise from premalignant polyps. Here, we report a case of concurrence of villous adenoma and non-muscle invasive bladder cancer. Case presentation: An 85-year-old woman presented at our office because of gross hematuria. Cystoscopic examination detected two papillary tumors in the bladder. Each tumor was resected and diagnosed, respectively. Histopathology confirmed that the resected one tumor was a villous adenoma, and the other was urothelial carcinoma (T1, high grade). Immunostaining for cytokeratin (CK) 7, CK20 and Ki-67 confirmed that CK7: (-), CK20: (+) and Ki-67: (<=30%) in villous adenoma while CK7: (+), CK20: (+), and Ki-67: (70%) in urothelial carcinoma. Three months later from TUR, urothelial carcinoma recurred in the trigone. She received adjuvant intravesical immunotherapy with BCG post TUR for the recurrence site. Conclusion: There were no specific findings on ultrasonography, CT, MRI or cystoscopic examination morphologically. Therefore, pre-pathological villous adenoma of the bladder is extremely difficult to diagnose. There are some case reports of solitary villous adenoma in the bladder or with coexisting adeno carcinoma. However, to the best of our knowledge, this is only the second report of villous adenoma in the bladder of coexisting urothelial carcinoma that has been published in the literature. Premalignant villous adenoma of the bladder is extremely rare and difficult to diagnose without histologic examination. Any suspicious lesion of the bladder should be biopsied and/or resected to confirm histology.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Current Clinical Trials in Non-muscle Invasive Bladder Cancer
    Nykopp, Timo K.
    da Costa, Jose Batista
    Mannas, Miles
    Black, Peter C.
    CURRENT UROLOGY REPORTS, 2018, 19 (12)
  • [32] Current clinical trials in non-muscle invasive bladder cancer
    Siddiqui, Mohammad Rashid
    Grant, Campbell
    Sanford, Thomas
    Agarwal, Piyush K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (08) : 516 - 527
  • [33] Nachsorge des nicht muskelinvasiven HarnblasenkarzinomsAftercare of non-muscle invasive bladder cancer
    G. B. Schulz
    B. Schlenker
    C. G. Stief
    Der Urologe, 2019, 58 (8): : 943 - 952
  • [34] Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
    Chang, Sam S.
    Boorjian, Stephen A.
    Chou, Roger
    Clark, Peter E.
    Daneshmand, Siamak
    Konety, Badrinath R.
    Pruthi, Raj
    Quale, Diane Z.
    Ritch, Chad R.
    Seigne, John D.
    Skinner, Eila Curlee
    Smith, Norm D.
    McKiernan, James M.
    JOURNAL OF UROLOGY, 2016, 196 (04) : 1021 - 1029
  • [35] Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review
    Basile, Giuseppe
    de Angelis, Mario
    Leni, Riccardo
    Re, Chiara
    Longoni, Mattia
    Mari, Andrea
    Soria, Francesco
    Pradere, Benjamin
    Del Giudice, Francesco
    Laukhtina, Ekaterina
    D'Andrea, David
    Mori, Keiichiro
    Krajewski, Wojciech
    Albisinni, Simone
    Gallioli, Andrea
    Breda, Alberto
    Esperto, Francesco
    Briganti, Alberto
    Montorsi, Francesco
    Moschini, Marco
    Carando, Roberto
    MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (03): : 278 - 288
  • [36] Therapeutic Advances in Bladder Preservation for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
    Lange, Alyssa
    Madiraju, Srigita
    Petros, Firas G.
    CANCERS, 2025, 17 (04)
  • [37] The current role of circulating biomarkers in non-muscle invasive bladder cancer
    Rink, Michael
    Schwarzenbach, Heidi
    Vetterlein, Malte W.
    Riethdorf, Sabine
    Soave, Armin
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (01) : 61 - 75
  • [38] Recirculating endovesical chemohyperthermia in the treatment of non-muscle invasive bladder cancer
    Sousa Escandon, Alejandro
    Mata, Juan Leon
    Sousa-Gonzalez, Daniel
    Rodriguez Gomez, Silvia
    Pineiro Diaz, Idelfonso
    MEDICINA BALEAR, 2019, 34 (02): : 33 - 39
  • [39] Management of high-risk non-muscle invasive bladder cancer
    Brausi, M.
    Olaru, V.
    MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (04) : 255 - 260
  • [40] Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer
    Weintraub, Michael D.
    Li, Qingdi Quentin
    Agarwal, Piyush K.
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (05) : 656 - 660